GGE
0.004
100%
DTM
0.003
-40%
FHS
0.005
66.7%
SRH
0.175
-35.2%
TMK
0.003
50%
CRB
0.004
-33.3%
FIN
0.007
40%
JAV
0.002
-33.3%
KPO
0.007
40%
FNR
0.12
-29.4%
CMD
0.022
37.5%
WBE
0.005
-28.6%
DDT
0.004
33.3%
MDR
0.096
-26.2%
TASDA
0.02
33.3%
BNL
0.006
-25%
PCL
0.013
30%
HLS
1.155
-25%
ENV
0.009
28.6%
PHO
0.054
-22.9%
VRX
0.057
26.7%
KRR
0.007
-22.2%
CAV
0.005
25%
AMS
0.004
-20%
RLG
0.005
25%
IPB
0.004
-20%
TEM
0.005
25%
RGL
0.004
-20%
TNC
0.185
23.3%
JLL
0.38
-18.3%
FRS
0.047
20.5%
CHM
0.005
-16.7%
CRI
0.018
20%
IFG
0.005
-16.7%
CUF
0.006
20%
ODE
0.005
-16.7%
TG1
0.024
20%
AVH
2.5
-16.4%
THB
0.012
20%
MDI
0.018
-14.3%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Control Bionics (ASX:CBL): Expands global reach with exclusive UK and Ireland distribution agreement

Control Bionics (ASX:CBL) expands global reach with exclusive UK and Ireland distribution agreement.

• Exclusive distribution of NeuroNode® by Smart Box in the UK and Ireland.
• Access to Smart Box’s established network of healthcare professionals and end-users.
• Strengthening Control Bionics’ presence in the European market.

Jeremy Steele, CEO of Control Bionics, commented: “The NeuroNode® has already been paired with hundreds of Smart Box
devices and devices with Smart Box software around the world.”

Read the ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20240909/pdf/067np1hzgg2sbv.pdf

Write to us
  • © 2025 Copyright
  • The Stock Network
  • All rights reserved